{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:25:29Z","timestamp":1782789929066,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.mito.2007.01.004","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T11:19:14Z","timestamp":1175080754000},"page":"S146-S153","source":"Crossref","is-referenced-by-count":60,"special_numbering":"S","title":["Coenzyme Q treatment of neurodegenerative diseases of aging"],"prefix":"10.1016","volume":"7","author":[{"given":"Wendy R.","family":"Galpern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit E.","family":"Cudkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0197-0186(01)00126-7","article-title":"Mitochondrial dysfunction in progressive supranuclear palsy","volume":"40","author":"Albers","year":"2002","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.mito.2007.01.004_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/B:JOBB.0000041772.74810.92","article-title":"Mitochondrial dysfunction and oxidative damage in Alzheimer\u2019s and Parkinson\u2019s diseases and coenzyme Q10 as a potential treatment","volume":"36","author":"Beal","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"issue":"4","key":"10.1016\/j.mito.2007.01.004_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.410360613","article-title":"Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate","volume":"36","author":"Beal","year":"1994","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.mito.2007.01.004_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.410420416","article-title":"Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis","volume":"42","author":"Beal","year":"1997","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(97)01192-X","article-title":"Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice","volume":"783","author":"Beal","year":"1998","journal-title":"Brain Res."},{"issue":"5604","key":"10.1016\/j.mito.2007.01.004_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.mito.2007.01.004_bib9","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.mito.2007.01.004_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.mito.2007.01.004_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(06)70494-X","article-title":"Seminar on choreas","volume":"5","author":"Cardoso","year":"2006","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.mito.2007.01.004_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/mds.870110317","article-title":"Assessment of coenzyme Q10 tolerability in Huntington\u2019s disease","volume":"11","author":"Feigin","year":"1996","journal-title":"Mov. Disord"},{"issue":"5","key":"10.1016\/j.mito.2007.01.004_bib16","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.mito.2007.01.004_bib17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.mito.2007.01.004_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/01.wnl.0000187070.35365.d7","article-title":"Tolerance of high-dose (3000mg\/day) coenzyme Q10 in ALS","volume":"65","author":"Ferrante","year":"2005","journal-title":"Neurology"},{"issue":"5674","key":"10.1016\/j.mito.2007.01.004_bib19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1098966","article-title":"Biomedicine. Parkinson\u2019s-divergent causes, convergent mechanisms","volume":"304","author":"Greenamyre","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington\u2019s disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.mito.2007.01.004_bib22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneur.60.8.1170-b","article-title":"The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic","volume":"60","author":"Horstink","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mito.2007.01.004_bib23","doi-asserted-by":"crossref","unstructured":"Huntington Study Group, 2001. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57(3), 397\u2013404.","DOI":"10.1212\/WNL.57.3.397"},{"key":"10.1016\/j.mito.2007.01.004_bib24","unstructured":"Huntington Study Group, 2005. PRE2CARE: a dosage ranging trial of CoEnzymeQ10 in Huntington\u2019s disease and normal subjects. HDF Biennial Symposia, Cambridge, MA, [abstract]."},{"key":"10.1016\/j.mito.2007.01.004_bib25","article-title":"A bioequivalence study of Coenzyme Q10 in healthy subjects","author":"Hyson","year":"2005","journal-title":"Mov. Disorders"},{"issue":"12","key":"10.1016\/j.mito.2007.01.004_bib26","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mito.2007.01.004_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington\u2019s disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"issue":"15","key":"10.1016\/j.mito.2007.01.004_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"4587","key":"10.1016\/j.mito.2007.01.004_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mito.2007.01.004_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/01.wnl.0000201182.60750.66","article-title":"A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS","volume":"66","author":"Levy","year":"2006","journal-title":"Neurology"},{"issue":"8717","key":"10.1016\/j.mito.2007.01.004_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington\u2019s disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.mito.2007.01.004_bib33","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mito.2007.01.004_bib34","unstructured":"Medical Letter, 2006. Coenzyme Q10. Med. Lett. Drugs Ther. 48 (1229), 19\u201320."},{"issue":"8\u20139","key":"10.1016\/j.mito.2007.01.004_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s007020070050","article-title":"Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis","volume":"107","author":"Molina","year":"2000","journal-title":"J. Neural. Transm."},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson\u2019s disease","volume":"341","author":"Muller","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.mito.2007.01.004_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.mito.2007.01.004_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.410390204","article-title":"Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis","volume":"39","author":"Przedborski","year":"1996","journal-title":"Ann. Neurol."},{"issue":"6415","key":"10.1016\/j.mito.2007.01.004_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.mito.2007.01.004_bib43","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.mito.2007.01.004_bib45","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.410420221","article-title":"Coenzyme Q10 levels correlate with the activities of complexes I and II\/III in mitochondria from parkinsonian and nonparkinsonian subjects","volume":"42","author":"Shults","year":"1997","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","article-title":"Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients","volume":"50","author":"Shults","year":"1998","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.mito.2007.01.004_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","article-title":"Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson\u2019s disease","volume":"188","author":"Shults","year":"2004","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.410390210","article-title":"Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis","volume":"39","author":"Siklos","year":"1996","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2004.05.007","article-title":"Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson\u2019s disease","volume":"223","author":"Sohmiya","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2004.09.030","article-title":"An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients","volume":"228","author":"Sohmiya","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.mito.2007.01.004_bib53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/WNL.59.2.280","article-title":"Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998","volume":"59","author":"Sorenson","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2007.01.004_bib54","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group, 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6), 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.mito.2007.01.004_bib55","doi-asserted-by":"crossref","unstructured":"The NINDS NET-PD Investigators, 2007. A Randomized, Double Blind, Futility Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson\u2019s Disease. Neurology 68(1), 20\u201328.","DOI":"10.1212\/01.wnl.0000250355.28474.8e"},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000223353.34006.54","article-title":"Neuroprotective agents for clinical trials in ALS: a systematic assessment","volume":"67","author":"Traynor","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mito.2007.01.004_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.mito.2007.01.004_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","article-title":"Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis","volume":"156","author":"Wiedemann","year":"1998","journal-title":"J. Neurol. Sci."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156772490700058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156772490700058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T20:10:03Z","timestamp":1556309403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156772490700058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":58,"alternative-id":["S156772490700058X"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2007.01.004","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}